Online citations, reference lists, and bibliographies.
← Back to Search

CLINICAL COURSE OF CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA TREATED WITH INTRAVENOUS IMMUNOGLOBULIN G OR MEGADOSE METHYLPREDNISOLONE OR OBSERVED WITHOUT THERAPY

F. Duru, T. Fışgın, N. Yaralı, A. Kara
Published 2002 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The authors compared the prognosis in 50 children with acute immune thrombocytopenic purpura (ITP) who received intravenous immunoglobulin G (IVIG), megadose methylprednisolone (MDMP), or no therapy. Twenty-six children were observed with no therapy, 12 children received IVIG, and 12 children received MDMP. The percentage of the patients whose platelet counts increased at a level of > 20 2 10 9 /L and > 50 2 10 9 /L at 3 days after starting therapy was significantly higher in both IVIG and MDMP groups than in the no therapy group ( p < .01), but there was no significant difference at 10 and 30 days after initiation between the 3 groups ( p > .05 in each comparison). This result suggested that therapy does not increase the rate of recovery but shortens the duration of thrombocytopenia in the first days. Management decision in ITP is made on clinical condition rather than on platelet count and no treatment options is to be preferred even in the face of mucosal bleeding. If the patient has extensive bleeding and the decision is to treat, both IVIG and MDMP are equally effective in providing a safe platelet level early on.
This paper references
10.1016/S0140-6736(81)92400-4
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
P. Imbach (1981)
10.1016/S0140-6736(85)90400-3
INTRAVENOUS IMMUNOGLOBULIN VERSUS ORAL CORTICOSTEROIDS IN ACUTE IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD
P. Imbach (1985)
10.1182/blood.v67.1.203.203
Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration.
C. Kitchens (1986)
10.1111/j.1600-0609.1989.tb01466.x
High‐dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura
Ş. Özsoylu (1989)
10.1182/BLOOD.V77.8.1856.BLOODJOURNAL7781856
Oral megadose methylprednisolone for childhood acute idiopathic thrombocytopenic purpura.
S. Ozsoylu (1991)
10.1136/adc.67.8.1056
Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group.
O. Eden (1992)
10.1016/S0022-3476(05)80400-7
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura.
V. Blanchette (1993)
10.3109/08880019309029508
Oral megadose methylprednisolone versus intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.
S. Ozsoylu (1993)
10.1016/S0140-6736(94)92205-5
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura
V. Blanchette (1994)
10.1136/ADC.71.3.251
Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology.
J. Lilleyman (1994)
10.1016/S0022-3476(05)82024-4
Acute immune thrombocytopenic purpura: a comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin.
D. Albayrak (1994)
10.1182/BLOOD.V88.1.3.BLOODJOURNAL8813
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.
J. George (1996)
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the
J N George (1996)
10.1182/BLOOD.V89.4.1464
Acute idiopathic thrombocytopenic purpura--management in childhood.
G. Buchanan (1997)
10.1016/S0140-6736(97)04143-3
Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines
P. Bolton-Maggs (1997)
10.1016/S0950-3536(97)80053-4
6 Megakaryocytes and platelets in vascular disease
B. Loo (1997)
Acute idiopathic thrombocytopenic purpura--management in childhood.
Bolton-Maggs Ph (1997)
Megakaryocytes and platelets in vascular disease.
B. van der Loo (1997)
10.1055/S-2007-996053
Acute immune thrombocytopenia in childhood. Are we treating the platelet count?
A. Sutor (1998)
10.1111/j.1365-2141.1999.01409.x
Management of childhood idiopathic thrombocytopenic purpura
J. Lilleyman (1999)
10.1016/S0037-1963(00)90108-2
Approach to the investigation and management of immune thrombocytopenic purpura in children.
V. Blanchette (2000)
10.1067/MPD.2000.110123
The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment.
R. Dickerhoff (2000)



This paper is referenced by
10.1111/jth.15232
Biological stratification of clinical disease courses in childhood immune thrombocytopenia
D. Schmidt (2021)
10.1182/bloodadvances.2019000966
American Society of Hematology 2019 guidelines for immune thrombocytopenia.
C. Neunert (2019)
10.2174/1573396315666191023122542
First line treatments for newly diagnosed primary immune thrombocytopenia in children: a systematic review and network meta-analysis.
David Orlando Acero-Garcés (2019)
10.1016/J.CPEM.2018.05.007
Breaking Down Blood: Pediatric Immune Thrombocytopenia and Autoimmune Hemolytic Anemia in the Emergency Department
Richard T Graham (2018)
10.1182/blood-2018-02-830844
Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial.
K. M. Heitink-Pollé (2018)
10.1016/j.pedneo.2018.10.002
Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.
T. Güngör (2018)
10.5578/ced.66692
Çocuk Enfeksiyon Hastalıkları Kliniğinde İntravenöz İmmünoglobülin Kullanımının Klinik Endikasyonları
Z. Aydın (2017)
Artikel asli Intracranial hemorrhage in a child with acute immune thrombocytopenic purpura Made
K. Ariawati (2017)
10.1016/j.jaci.2016.09.023
Update on the use of immunoglobulin in human disease: A review of evidence
E. Perez (2017)
10.22038/IJP.2016.7096
Comparing the Outcomes of IVIg with Combination of IVIg and Methylprednisolone in Children with Acute Idiopathic Thrombocytopenia; a Bayesian Logistic Approach
Seyed Kamal Eshagh-Hoseini (2016)
10.1001/jamapediatrics.2014.2214
Influence of the American Society of Hematology guidelines on the management of newly diagnosed childhood immune thrombocytopenia.
Corinna L Schultz (2014)
10.4274/Tjh.2012.0049
Childhood Immune Thrombocytopenia: Long-term Follow-up Data Evaluated by the Criteria of the International Working Group on Immune Thrombocytopenic Purpura
M. Evim (2014)
10.1002/pbc.24628
Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children
M. Deel (2013)
10.1016/j.ctim.2013.08.005
Alternative therapy for persistent childhood immune thrombocytopenic purpura unresponsive to intravenous immunoglobulin.
Tzu-Ping Huang (2013)
10.1007/s00431-013-2254-6
Clinical practice: immune thrombocytopenia in paediatrics
V. Labarque (2013)
Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.
G. Blackhouse (2012)
10.4274/TPA.1659
2011 yılında çocukluk çağı immün trombositopenik purpura hastalığı izlem ve tedavisinde değişiklikler
T. Celkan (2012)
10.1182/blood-2010-08-302984
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.
C. Neunert (2011)
guideline for immune thrombocytopenia The American Society of Hematology 2011 evidence-based practice
C. Neunert (2011)
10.1016/J.CPEM.2011.07.004
Recognition and Management of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia in the Emergency Department
A. Sobota (2011)
10.1007/s12016-009-8155-9
Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature
S. Kivity (2010)
10.1080/08880010903044540
CLINICAL FEATURES, TREATMENT RESPONSES, AND OUTCOME OF CHILDREN WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
F. Demircioğlu (2009)
10.1111/j.1365-2141.2009.07743.x
Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS)
R. Tamminga (2009)
10.1097/MPH.0b013e318180bbc9
Late Side Effects of High-dose Steroid Therapy on Skeletal System in Children With Idiopathic Thrombocytopenic Purpura
Zühal Keskin Yildirim (2008)
Supporting Informed Decisions Polyclonal Intravenous Immunoglobulin in Patients with Immune Thrombocytopenic Purpura : Clinical Systematic
Stella Chen (2008)
10.1016/J.TMRV.2007.01.001
Guidelines on the use of intravenous immune globulin for hematologic conditions.
D. Anderson (2007)
10.1097/MOH.0b013e3282ab98df
Update on the management of immune thrombocytopenic purpura in children
M. Tarantino (2007)
Acute immune thrombocytopenic purpura in children.
A. Rehman (2007)
Tratamiento desde el inicio o actitud expectante en el niño con púrpura trombopénica idiopática aguda
E. Monteagudo (2007)
10.1002/pbc.20830
A cost‐utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP)
Sarah H. O'Brien (2007)
10.1007/s00112-006-1350-3
Strategien zur Behandlung von Thrombozytopenien im Kindesalter
W. Ebell (2006)
Recent Advances in the Treatment of Childhood
M. Tarantino (2006)
See more
Semantic Scholar Logo Some data provided by SemanticScholar